| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.124 | 54.926 | 75.877 | 99.989 | 106.195 |
| Total Income - EUR | - | - | - | - | - | 11.124 | 54.926 | 75.877 | 99.992 | 128.085 |
| Total Expenses - EUR | - | - | - | - | - | 7.549 | 24.886 | 36.268 | 38.151 | 74.204 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 3.575 | 30.040 | 39.609 | 61.841 | 53.881 |
| Net Profit/Loss - EUR | - | - | - | - | - | 3.464 | 29.490 | 38.850 | 60.841 | 50.038 |
| Employees | - | - | - | - | - | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Nutrique Diab Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 169 | 144 | 122 | 100 | 78 |
| Current Assets | - | - | - | - | - | 5.002 | 34.272 | 44.341 | 73.317 | 61.945 |
| Inventories | - | - | - | - | - | 118 | 457 | 1.312 | 1.414 | 2.128 |
| Receivables | - | - | - | - | - | 2.109 | 24.367 | 32.039 | 48.439 | 48.768 |
| Cash | - | - | - | - | - | 2.775 | 9.448 | 10.990 | 23.464 | 11.050 |
| Shareholders Funds | - | - | - | - | - | 3.505 | 32.918 | 42.297 | 67.631 | 53.415 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.666 | 1.498 | 2.167 | 5.787 | 8.608 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nutrique Diab Clinique S.r.l.